AccuStem Sciences, Inc.
ACUT
$0.28
-$0.04-12.50%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 19.54% | 10.24% | 44.27% | -18.14% | 110.93% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 38.24% | 21.85% | 44.28% | -16.37% | 51.26% |
| Operating Income | -38.24% | -21.85% | -44.28% | 16.37% | -51.26% |
| Income Before Tax | -38.24% | -21.85% | -44.28% | 16.37% | -51.26% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -38.24% | -21.85% | -44.28% | 16.37% | -51.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -38.24% | -21.85% | -44.28% | 16.37% | -51.26% |
| EBIT | -38.24% | -21.85% | -44.28% | 16.37% | -51.26% |
| EBITDA | -38.58% | -22.18% | -44.72% | 16.28% | -51.45% |
| EPS Basic | -0.63% | 13.84% | -2.04% | 25.43% | -46.54% |
| Normalized Basic EPS | -0.50% | 13.81% | -1.96% | 25.52% | -46.32% |
| EPS Diluted | -0.63% | 13.84% | -2.04% | 25.43% | -46.54% |
| Normalized Diluted EPS | -0.50% | 13.81% | -1.96% | 25.52% | -46.32% |
| Average Basic Shares Outstanding | 37.43% | 41.65% | 41.65% | 12.14% | 3.13% |
| Average Diluted Shares Outstanding | 37.43% | 41.65% | 41.65% | 12.14% | 3.13% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |